Clinical trial
Study of GL701 in Men With Systemic Lupus Erythematosus
NCT00037128 · Genelabs Technologies, Industry · Unknown status
Key facts
| NCT number | NCT00037128 |
|---|---|
| Title | Study of GL701 in Men With Systemic Lupus Erythematosus |
| Lead sponsor | Genelabs Technologies, Industry |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Systemic Lupus Erythematosus |
| Intervention type | Drug |
| Interventions | GL701 |
| Enrollment | 40 |
| Start date | Mar 1, 1998 |
| First posted | May 17, 2002 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: